Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group.

Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, Kalish LA.

N Engl J Med. 1997 May 8;336(19):1337-42.

2.

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF.

N Engl J Med. 1999 Aug 5;341(6):394-402.

3.

Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.

Rouet F, Sakarovitch C, Msellati P, Elenga N, Montcho C, Viho I, Blanche S, Rouzioux C, Dabis F, Leroy V; Abidjan ANRS 049 Ditrame Study Group..

Pediatrics. 2003 Oct;112(4):e289.

PMID:
14523214
4.

Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.

Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, Hanson IC, Cooper E, Mendez H.

Pediatrics. 2000 Jan;105(1):e8.

PMID:
10617745
5.

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC.

N Engl J Med. 2001 Mar 8;344(10):720-5.

6.

A trial of three antiretroviral regimens in HIV-1-infected children.

Luzuriaga K, McManus M, Mofenson L, Britto P, Graham B, Sullivan JL; PACTG 356 Investigators..

N Engl J Med. 2004 Jun 10;350(24):2471-80.

7.

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis.

Ioannidis JP, Tatsioni A, Abrams EJ, Bulterys M, Coombs RW, Goedert JJ, Korber BT, Mayaux MJ, Mofenson LM, Moye J Jr, Newell ML, Shapiro DE, Teglas JP, Thompson B, Wiener J.

AIDS. 2004 Jan 2;18(1):99-108.

PMID:
15090835
8.

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL.

N Engl J Med. 1996 Nov 28;335(22):1621-9.

9.

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.

N Engl J Med. 1999 Aug 5;341(6):385-93.

10.

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.

Abrams EJ, Weedon J, Steketee RW, Lambert G, Bamji M, Brown T, Kalish ML, Schoenbaum EE, Thomas PA, Thea DM.

J Infect Dis. 1998 Jul;178(1):101-8.

PMID:
9652428
11.

Virus levels in untreated African infants infected with human immunodeficiency virus type 1.

Biggar RJ, Janes M, Pilon R, Miotti P, Taha TE, Broadhead R, Mtimivalye L, Kumwenda N, Cassol S.

J Infect Dis. 1999 Dec;180(6):1838-43.

PMID:
10558939
12.

Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes.

Young NL, Shaffer N, Chaowanachan T, Chotpitayasunondh T, Vanparapar N, Mock PA, Waranawat N, Chokephaibulkit K, Chuachoowong R, Wasinrapee P, Mastro TD, Simonds RJ; Bangkok Collaborative Perinatal HIV Transmission Study Group..

J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):401-7.

PMID:
11035610
14.

TT virus infection in human immunodeficiency virus type 1 infected mothers and their infants.

de Martino M, Moriondo M, Azzari C, Resti M, Galli L, Vierucci A.

J Med Virol. 2000 Jul;61(3):347-51.

PMID:
10861644
15.

Predictive markers of clinical outcome in vertically HIV-1-infected infants. A prospective longitudinal study.

Resino S, Gurbindo D, Cano JM, Sanchez-Ramón S, Muõz-Fernández MA.

Pediatr Res. 2000 Apr;47(4 Pt 1):509-15.

PMID:
10759159
16.

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH.

N Engl J Med. 2000 Mar 30;342(13):921-9.

18.

Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children.

Abrams EJ, Wiener J, Carter R, Kuhn L, Palumbo P, Nesheim S, Lee F, Vink P, Bulterys M; Perinatal AIDS Collaborative Transmission Study (PACTS) Group..

AIDS. 2003 Apr 11;17(6):867-77.

PMID:
12660534
19.

Long-term pattern of HIV-1 RNA load in perinatally infected children.

Navér L, Ehrnst A, Belfrage E, Sönnerborg A, Lidin-Janson G, Christensson B, Ljung R, Bohlin AB.

Scand J Infect Dis. 1999;31(4):337-43.

PMID:
10528869
20.

Supplemental Content

Support Center